Therapeutic progress in lung squamous cell carcinoma has lagged, with recent antiangiogenic–checkpoint inhibitor combinations failing primary endpoints despite improved safety, underscoring unmet need ...
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...
Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...
Lung cancer is now the leading cause of cancer deaths in the United States, claiming more lives than several other major cancers combined.
Social media advertising reached over one million adults eligible for lung cancer screening, showing a scalable way to boost ...
Everyday Health on MSN
Severe Flu or COVID-19 Could Raise Lung Cancer Risk
In a new study, researchers found that being hospitalized for flu or COVID-19 was linked to a 24 percent increase in later lung cancer risk. Learn how to protect yourself.
How Well Does Tagrisso Work for Lung Cancer? The FDA approved Tagrisso based on clinical trials for EGFR-mutated lung cancer in several different scenarios. Tagrisso was studied in people who had lung ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
Imagine you go to the healthcare provider because you have a bad cough, or maybe you fell and hurt your ribs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results